NRC at a glance
NATIONAL RESEARCH CORP (NRC, SEC CIK 70487) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on October 27, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), NATIONAL RESEARCH CORP (NRC) reported revenue of $137.4 million (down 4.0% from FY2024) and net income of $11.3 million. Diluted EPS was $50.00.
- As of September 30, 2026, 24 institutional investment managers tracked by SignalX reported holding NATIONAL RESEARCH CORP (NRC) shares worth $107.5 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by HARRISON SHANE R on February 17, 2026 of 8,000 shares at $12.27 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $137.4M
- −4.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 24 funds
- $107.5M · −1 vs prior quarter
- Latest 8-K
- Oct 27, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to risk factors since the December 31, 2025 Form 10-K
- Significant carried-forward risks remain those described in the 2025 Form 10-K
- Business, financial condition, and operating results remain exposed to material adverse effects from those risks
Management Discussion & Analysis
- Q3 revenue $38.4M, up $3.8M YoY, driven by $3.2M existing-customer recurring revenue growth
- Operating income $8.9M vs $7.7M YoY, operating margin 23.2% vs 22.4%
- Adjusted EBITDA $10.9M, adjusted EBITDA margin 28.3% vs 31.4% YoY
- Q3 operating cash flow $8.0M vs $13.8M, free cash flow $7.0M vs $10.2M
- Q3 share repurchases $16.7M, additional dividends $3.4M declared; liquidity $3.6M cash and $18.0M revolver availability
AI summary of the NRC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Third-quarter fiscal 2026 results released for period ended September 30, 2026
- Full financial and operating metrics available in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Q3 revenue $38.4M, up 11% YoY, signaling continued demand and customer contract conversion
- TRCV $154.1M, up 9% YoY, supporting future recurring-revenue visibility
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CEO Trent Green appointed interim principal financial officer effective October 14, 2026
- Dual CEO and finance leadership concentrates oversight with one executive
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CFO Shane Harrison resigning effective August 28, 2026 to pursue an outside professional opportunity
- CFO transition creates near-term financial leadership and reporting continuity risk
AI summaries of NRC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NRC
Don't miss the next NRC filing
- Alerts as it files. A push when NRC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NRC, by share count.
- Ask anything. An AI agent that reads every NRC filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Hrdy Helen | F | Nov 10, 2026 | 10,491 | $26.67 |
| Hrdy Helen | M | Nov 10, 2026 | 12,619 | $18.80 |
| Hrdy Helen | M | Nov 10, 2026 | 12,619 | - |
| NUNNELLY JOHN N | A | Jun 23, 2026 | 7,697 | - |
| Bhandari Parul | A | Jun 23, 2026 | 7,697 | - |
| Wheeler Penny Ann | A | Jun 23, 2026 | 7,697 | - |
| Lockhart Stephen H | A | Jun 23, 2026 | 7,697 | - |
| Berwick Donald M | A | Jun 23, 2026 | 7,697 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $143.1M | $137.4M |
| Operating Income | - | $35.2M | $22.6M |
| Net Income | $31.0M | $24.8M | $11.3M |
| Op. Margin | - | 24.6% | 16.4% |
| Net Margin | - | 17.3% | 8.2% |
| Balance Sheet | |||
| Total Assets | $122.4M | $132.5M | $134.9M |
| Equity | - | $31.3M | $14.0M |
| ROE | - | 79.2% | 80.7% |
| Per Share | |||
| EPS | $1.25 | $1.04 | $50.00 |
| Cash Flow | |||
| Operating CF | - | $34.6M | $26.4M |
| CapEx | $15.8M | $15.4M | $10.7M |
Source: XBRL data in NATIONAL RESEARCH CORP (NRC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate NRC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 24 | $107.5M |
| Q2 2026 | 25 | $109.6M |
| Q1 2026 | 23 | $86.9M |
| Q4 2025 | 22 | $98.8M |
| Q3 2025 | 25 | $68.9M |
| Q2 2025 | 25 | $94.8M |
| Q1 2025 | 24 | $57.5M |
| Q4 2024 | 19 | $59.5M |
- Citadel Advisors LLC+54.9K (+86%)
- Mangrove Partners+32.1K (+243%)
- BNY Mellon+19.1K (+8%)
- Bank of America Corp+6.2K (+7%)
- Goldman Sachs Group+5.2K (+5%)
- Wells Fargo & Co−21.1K (-12%)
- AQR Capital Management−15.7K (-13%)
- Vanguard Capital Management LLC−14.2K (-2%)
- Renaissance Technologies LLC−11.8K (-4%)
- BlackRock−7.1K (-1%)
- Millennium Management+14.3K
- Two Sigma Investments−62.9K
- FMR LLC (Fidelity)−2.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 187 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NRC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 12, 2026 | - | - | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 27, 2026 | - | Analysis | - |
| 8-K | Oct 19, 2026 | - | Analysis | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 8-K | Jun 29, 2026 | - | Analysis | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 28, 2026 | - | Analysis | - |
| 8-K | Apr 28, 2026 | - | Analysis | - |
| 8-K | Apr 20, 2026 | - | Analysis | - |
| 4 | Mar 13, 2026 | - | - | - |
| 8-K | Mar 5, 2026 | - | Analysis | - |
| 10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
| 4 | Feb 19, 2026 | - | - | |
| 4 | Feb 17, 2026 | - | - | |
| 4 | Feb 17, 2026 | - | - | |
| 8-K | Feb 3, 2026 | - | - | |
| 4 | Jan 26, 2026 | - | - |
Related Health Care companies
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
- CRL · Charles River LaboratoriesServices-Commercial Physical & Biological Research
- INCY · IncyteServices-Commercial Physical & Biological Research
- IQV · IQVIAServices-Commercial Physical & Biological Research
- MXCT · MAXCYTE, INC.Services-Commercial Physical & Biological Research
- MEDP · Medpace Holdings IncServices-Commercial Physical & Biological Research
- OABI · OmniAb, Inc.Services-Commercial Physical & Biological Research
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
NRC SEC filings: frequently asked questions
Which institutions hold NRC stock?
As of September 30, 2026, the largest NATIONAL RESEARCH CORP (NRC) holders among the 13F filers tracked by SignalX were BlackRock ($22.3 million), Morgan Stanley ($18.1 million), Vanguard Capital Management LLC ($13.8 million), Dimensional Fund Advisors ($10.4 million), Renaissance Technologies LLC ($6.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NRC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), NATIONAL RESEARCH CORP (NRC) reported revenue of $137.4 million (down 4.0% from FY2024) and net income of $11.3 million. Diluted EPS was $50.00. The figures come from the XBRL data in the 10-K.
What did NRC report in its latest 8-K?
NATIONAL RESEARCH CORP (NRC) filed an 8-K on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Third-quarter fiscal 2026 results released for period ended September 30, 2026.
What are the latest NRC SEC filings?
NATIONAL RESEARCH CORP (NRC) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on October 27, 2026 and a Form 4 insider filing on November 12, 2026.
What is NRC's SEC CIK number?
NATIONAL RESEARCH CORP (NRC)'s SEC Central Index Key (CIK) is 70487. EDGAR lists every NRC filing under that number.
Ask anything about NRC
The research agent reads NRC's filings, financials, insider trades and 13F holders, then answers with sources.